PINK1/Parkin介导的线粒体自噬功能障碍在hIAPP聚积致椎间盘退变中的作用及机制研究

批准号:
81974349
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
吴星火
依托单位:
学科分类:
骨、关节、软组织退行性病变
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
吴星火
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
我们和其他研究证实,在椎间盘退变(IDD)过程中,β-淀粉样蛋白hIAPP异常聚积导致髓核细胞(NPCs)线粒体损伤和自噬功能障碍,加速椎间盘损伤与退变;而PINK1/Parkin信号通路能够增强线粒体自噬,促进受损的线粒体的清除,维持细胞内部环境相对稳定。据此我们推测,hIAPP聚积导致PINK1/Parkin介导的线粒体自噬功能障碍,在IDD发病机制中扮演重要角色;通过该通路激活线粒体自噬,能够减轻hIAPP聚积所致线粒体损伤与功能紊乱,是IDD致病重要调节机制之一。本研究拟通过临床标本测定、细胞实验和动物模型研究,以hIAPP聚集体诱导髓核细胞损伤为切入点,阐明PINK1/Parkin介导的线粒体自噬功能障碍在椎间盘退变的作用及机制,并探究hIAPP聚积与IDD的相关性。本研究有望揭示IDD精确分子机制、设计靶向治疗药物、探索IDD生物学治疗新方法。
英文摘要
Our and other studies have confirmed that β-amyloid deposition of human islet amyloid polypeptide (hIAPP) lead to dysfunctional and abnormal of autophagy and mitochondrial function in nucleus pulposus cells (NPCs) during intervertebral disc degeneration (IDD), eventually resulted in disc degeneration or injury.PINK1/Parkin-dependent mechanism can enhance mitochondrial autophagy and promote the clearance of damaged mitochondria.Therefore, we hypothesized that hIAPP aggregation resulted in PINK1/Parkin mediated mitophagy inhibition, which was a novel mechanism of IDD.Mitochondrial damage and dysfunction caused by hIAPP aggregation could be alleviated through the activation of PINK1/Parkin medicated mitochondrial autophagy, which is one of the important regulatory mechanisms of IDD pathogenesis. Based on the latest literatures and our previous research, this study takes NPCs degeneration induced by hIAPP aggregation as the breakthrough point, to elucidate the role and mechanism of PINK1/Parkin mediated mitophagy inhibition in IDD, and to explore the relationship between hIAPP aggregation and IDD. It’s of groundbreaking significance to reveal the precise molecular mechanism, design targeted therapeutic drugs and explore biological treatment methods for IDD.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.mehy.2021.110758
发表时间:2022-01-06
期刊:MEDICAL HYPOTHESES
影响因子:4.7
作者:Cheng, Chuan;Xu, Zhiqiang;Wu, Xinghuo
通讯作者:Wu, Xinghuo
DOI:10.1016/j.bbrc.2023.02.074
发表时间:2023-03
期刊:Biochemical and biophysical research communications
影响因子:3.1
作者:Shouyuan Chi;Suyun Li;Zhiqiang Xu;Guoyu Yang;Yu Song;Zhiwei Liao;Cao Yang;Xinghuo Wu
通讯作者:Shouyuan Chi;Suyun Li;Zhiqiang Xu;Guoyu Yang;Yu Song;Zhiwei Liao;Cao Yang;Xinghuo Wu
DOI:10.1016/j.mehy.2020.109739
发表时间:2020-04
期刊:Medical hypotheses
影响因子:4.7
作者:Xiaodan Zheng;Ping Liu;Cao Yang;Xinghuo Wu
通讯作者:Xiaodan Zheng;Ping Liu;Cao Yang;Xinghuo Wu
DOI:10.3389/fbioe.2022.740507
发表时间:2022
期刊:Frontiers in bioengineering and biotechnology
影响因子:5.7
作者:Lu L;Wang H;Liu P;Liu R;Zhang J;Xie Y;Liu S;Huo T;Xie M;Wu X;Ye Z
通讯作者:Ye Z
DOI:10.1002/ctm2.1494
发表时间:2023-12
期刊:CLINICAL AND TRANSLATIONAL MEDICINE
影响因子:10.6
作者:Liao, Zhiwei;Tong, Bide;Zhang, Xiaoguang;Zhang, Weifeng;Ke, Wencan;Liang, Huaizhen;Lei, Ming;Hua, Wenbin;Li, Shuai;Song, Yu;Wu, Xinghuo;Yang, Cao
通讯作者:Yang, Cao
脂肪组织巨噬细胞(ATMs)替代激活及调控在股骨头坏死发病机制及治疗中的作用研究
- 批准号:81201393
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2012
- 负责人:吴星火
- 依托单位:
国内基金
海外基金
